Health
Potency-enhancing drugs show ability to improve prognosis in patients with colorectal cancer – News-Medical.Net
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer.
A new study from Lund University and Region Skåne in Sweden indicates that potency-enhancing PDE5 inhibitor drugs have an anti-cancer potential with the ability to improve the prognosis in patients with colorectal cancer. PDE5 inhibitors include a few approved drugs in which sildenafil (Viagra) is the most well-known. The article is published in Nature Communications.
Available preclinical evidence suggests that PDE5 inhibitors could slow down the tumor growth and progression in mice, but it is…
-
Noosa News22 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Noosa News18 hours agoDriver arrested after life-threatening hit-and-run on outskirts of Ipswich, Queensland
-
Business20 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
General23 hours agoMelbourne AFLW skipper Kate Hore backs league’s future, citing rising skills and talent